search
Back to results

Effects of Green-MED Diet Via the Gut-fat-brain Axis (DIRECT-PLUS)

Primary Purpose

Abdominal Obesity Metabolic Syndrome

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Physical activity
Physical activity+ MED diet
Physical activity+green MED diet
Sponsored by
Ben-Gurion University of the Negev
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Abdominal Obesity Metabolic Syndrome

Eligibility Criteria

30 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

age >30 years with abdominal adiposity (waist circumference: men > 102 cm, women > 88 cm) or dyslipidemia (TG>150mg/dl and HDL-c <40mg/dL for men and <50mg/dL for women)

Exclusion Criteria:

Individuals who may not be able to partake in PA in the gym; TGs>400 mg/dL; serum creatinine>2 mg/dL; disturbed liver function; major illness that might require hospitalization; pregnant or lactating women; presence of active cancer, is receiving or received chemotherapy in the last three years; participation in another trial; participants who are treated with Coumadin (warfarin) - given its interaction with vitamin K and high level of this vitamin in "Mankai" green shake; pacemaker or platinum implant, because of the impossibility of MRI screening.

Sites / Locations

  • Nuclear research center Negev

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Experimental

Arm Label

Physical activity

Physical activity+ MED diet

Physical activity+ green-MED diet

Arm Description

Physical activity (PA) group will receive free gym memberships and the instruction necessary to engage in moderate-intensity physical activity, ~80% of which will have an aerobic component. The participants will get basic health promoting guideline for healthy diet .

On top of the PA intervention described in Arm 1, the participants will be guided for moderate weight loss with a traditional Mediterranean (MED) diet, low in simple carbohydrates. The diet will include 1oz/day of walnuts that will be provided free of charge.

On top of the PA intervention described in Arm 1, the participants will guided for moderate weight loss with a MED diet, low in simple carbohydrates that will be rich in plants and polyphenols and low in processed meat. The diet will include 1oz/day of walnuts, 3-4 cups/day of green tea and ~500cc green shake/dinner based on specific strain of duckweed [Wolffia globose, "Mankai"], an aquatic plant, which might serve as a plant protein source. All the above will be provided free of charge.

Outcomes

Primary Outcome Measures

Abdominal fat
Changes in visceral fat (MRI)
Hepatic fat
Changes in hepatic fat (MRI)
Obesity
Changes in body weight and waist circumference

Secondary Outcome Measures

Brain anatomy
Changes in hippocampus volume, diffusion Tensor Imaging (MRI)
Cognitive function-MRI
Changes in resting state connectivity (MRI, sub-study)
Cognitive function
cognitive tests
Cardiac state
Changes in cardiac anatomy (MRI, substudy)
Cardiac state
Changes in cardiac function (MRI, substudy)
Endothelial dysfunction
Changes endothelial function (ECG)
Lipid profile
Changes in lipid biomarkers (blood draw)
Glycemic control
Changes in glycemic biomarkers (blood draw)
Inflammatory state
Changes in inflammatory biomarkers (blood draw)
Metabolomic
Changes in sub-lipids (blood draw)
Metabolomic
Changes in sub-proteins ( blood draw)
Liver function (blood biomarkers)
Changes in liver function biomarkers (blood draw)
Genetic signature
SNPs associated with fat distribution and visceral fat
Epigenetics
changes in mRNAs
Epigenetics
changes in genes' methylation
Well being
assessed by questionnaire
Fecal microbiota profile
Diversity Index as a key measure
24h- continuous glucose levels
24h dynamics of glucose using continuous glucose monitor. substudy

Full Information

First Posted
January 9, 2017
Last Updated
July 11, 2019
Sponsor
Ben-Gurion University of the Negev
Collaborators
Harvard School of Public Health (HSPH), University of Leipzig
search

1. Study Identification

Unique Protocol Identification Number
NCT03020186
Brief Title
Effects of Green-MED Diet Via the Gut-fat-brain Axis
Acronym
DIRECT-PLUS
Official Title
Effects of Green-MED Diet Via the Gut-fat-brain Axis; DIRECT-PLUS
Study Type
Interventional

2. Study Status

Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
March 2019 (Actual)
Study Completion Date
March 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ben-Gurion University of the Negev
Collaborators
Harvard School of Public Health (HSPH), University of Leipzig

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Mediterranean (MED) diet, richer in plants/seeds (and dietary polyphenols) and low in processed meat (green-MED diet) may have a pronounced beneficial effect on age-related declines that begin in middle age, reflected by changes in adiposity, cognitive function, and cardiometabolic risk. The investigators hypothesize that long-term intake of this diet will significantly potentiate the effects of a healthy lifestyle (physical activity and Mediterranean diet), constituting a powerful strategy to halt or even reverse the progression of several age-related processes related to adiposity, cardiometabolic health and cognition. The investigators further hypothesize that lifestyle intervention might modify the gut microbiota profile and that autologous fecal microbiota supplement derived from the time of maximal weight loss might halt the expected subsequent regain phase.
Detailed Description
The investigators aim to compare the effect of green-MED diet+ physical activity (PA) vs. MED diet+ PA vs. PA on the gut-fat-brain axis and to explore the additional contribution of autologous fecal microbiota derived at the rapid weight loss phase on regain phase. Mediterranean (MED) diet, richer in plants/seeds (and dietary polyphenols) and low in processed meat may have a pronounced beneficial effect on age-related declines that begin in middle age, reflected by changes in adiposity, cognitive function, and cardiometabolic risk. The investigators hypothesize that long-term intake of this diet will significantly potentiate the effects of a healthy lifestyle (physical activity and Mediterranean diet), constituting a powerful strategy to halt or even reverse the progression of several age-related processes related to adiposity, cardiometabolic health and cognition. The investigators further hypothesize that lifestyle intervention might modify the gut microbiota profile and that autologous fecal microbiota supplement derived from the time of maximal weight loss might halt the expected subsequent regain phase. The investigators will follow the participants with magnetic resonance imaging (MRI) that will include abdominal and hepatic fat, cardiac and anatomic/functional brain assessments. The investigators will perform cognitive tests and will measure changes in gut microbiota and sub-metabolomic profiling. The trial will be performed in an isolated workplace (the Nuclear Research Center) which holds an exclusive cafeteria that provides free, dietary -monitored, lunch, and an internal medical department. The exclusive nutritional profile of walnuts, with its relative high polyphenols content and unique composition, may benefit several health outcomes. Epidemiologic studies and RCTs suggest that walnuts consumption is associated with better weight status, adiposity measures and cardiometabolic state. However, some individuals avoid walnuts because they are calorie-dense, and fear that they will promote weight gain. Walnuts contain numerous well-characterized beneficial nutritional components, such as unsaturated fats, especially omega-3 fatty acids, dietary fibers, and high levels of vitamins and minerals. Among other well-recognized components, nuts are highly rich in polyphenols, mainly flavonoids. Polyphenols may potentially interact with physical activity and promote neurogenesis; a process that may significantly contribute to the brain's ageing process. Similarly, the polyphenol epigallocatechin-3-gallate (EGCG, a type of catechin found in green tea), was proposed to exert neuroprotective effects. New specific developed strain of duckweed [Wolffia globose, "Mankai"] , an aquatic plant, which might serve as a protein source and contains all the 9 essential and the 6 conditional amino acids. "Mankai" [(Generally recognized as safe (GRAS)] is a cultivated strain of Wolffia globosa, which is an aquatic plant, part of the family of plants known commonly as duckweeds. Duckweeds are very simple flowering aquatic plants, which float on or just beneath the surface of still or slow-moving bodies of water. There is a long history of the use of Wolffia species, in particular Wolffia Globosa, as food, especially in Southeast Asia: Burma, Laos and northern Thailand, where it has been used as a vegetable for many generations. The nutritional composition of "Mankai" has been determined and found to be high in protein, containing all the essential and conditionally essential amino acids, dietary fibers and several vitamins and minerals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Abdominal Obesity Metabolic Syndrome

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
294 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physical activity
Arm Type
Placebo Comparator
Arm Description
Physical activity (PA) group will receive free gym memberships and the instruction necessary to engage in moderate-intensity physical activity, ~80% of which will have an aerobic component. The participants will get basic health promoting guideline for healthy diet .
Arm Title
Physical activity+ MED diet
Arm Type
Experimental
Arm Description
On top of the PA intervention described in Arm 1, the participants will be guided for moderate weight loss with a traditional Mediterranean (MED) diet, low in simple carbohydrates. The diet will include 1oz/day of walnuts that will be provided free of charge.
Arm Title
Physical activity+ green-MED diet
Arm Type
Experimental
Arm Description
On top of the PA intervention described in Arm 1, the participants will guided for moderate weight loss with a MED diet, low in simple carbohydrates that will be rich in plants and polyphenols and low in processed meat. The diet will include 1oz/day of walnuts, 3-4 cups/day of green tea and ~500cc green shake/dinner based on specific strain of duckweed [Wolffia globose, "Mankai"], an aquatic plant, which might serve as a plant protein source. All the above will be provided free of charge.
Intervention Type
Other
Intervention Name(s)
Physical activity
Intervention Type
Other
Intervention Name(s)
Physical activity+ MED diet
Intervention Type
Other
Intervention Name(s)
Physical activity+green MED diet
Intervention Description
****Sub-study from all 3 main arms: Autologous fecal microbiota supplement intervention derived from the time of maximal weight loss: At the 6-month time period, the time of anticipated greatest weight reduction, participants's feces samples will be processed to capsulized inocula. Samples will be frozen within 2 hours and will be kept at -80c pending analysis. Participants will be randomized to receive either research capsules or identical placebo capsules between 8 and 14 months time period. Placebo capsules will consist of a combination of powdered cocoa and vegetable gelatin in normal saline/glycerol and will be identical in appearance to research capsules.
Primary Outcome Measure Information:
Title
Abdominal fat
Description
Changes in visceral fat (MRI)
Time Frame
18 months
Title
Hepatic fat
Description
Changes in hepatic fat (MRI)
Time Frame
18 months
Title
Obesity
Description
Changes in body weight and waist circumference
Time Frame
6, 14, 18 months
Secondary Outcome Measure Information:
Title
Brain anatomy
Description
Changes in hippocampus volume, diffusion Tensor Imaging (MRI)
Time Frame
18 months
Title
Cognitive function-MRI
Description
Changes in resting state connectivity (MRI, sub-study)
Time Frame
18 months
Title
Cognitive function
Description
cognitive tests
Time Frame
18 months
Title
Cardiac state
Description
Changes in cardiac anatomy (MRI, substudy)
Time Frame
18 months
Title
Cardiac state
Description
Changes in cardiac function (MRI, substudy)
Time Frame
18 months
Title
Endothelial dysfunction
Description
Changes endothelial function (ECG)
Time Frame
18 months
Title
Lipid profile
Description
Changes in lipid biomarkers (blood draw)
Time Frame
6 , 14 and 18 months
Title
Glycemic control
Description
Changes in glycemic biomarkers (blood draw)
Time Frame
6 , 14 and 18 months
Title
Inflammatory state
Description
Changes in inflammatory biomarkers (blood draw)
Time Frame
6 , 14 and 18 months
Title
Metabolomic
Description
Changes in sub-lipids (blood draw)
Time Frame
18 months
Title
Metabolomic
Description
Changes in sub-proteins ( blood draw)
Time Frame
18 months
Title
Liver function (blood biomarkers)
Description
Changes in liver function biomarkers (blood draw)
Time Frame
6 and 18 months
Title
Genetic signature
Description
SNPs associated with fat distribution and visceral fat
Time Frame
baseline
Title
Epigenetics
Description
changes in mRNAs
Time Frame
18 months
Title
Epigenetics
Description
changes in genes' methylation
Time Frame
18 months
Title
Well being
Description
assessed by questionnaire
Time Frame
18 months
Title
Fecal microbiota profile
Description
Diversity Index as a key measure
Time Frame
6, 14, 18 months
Title
24h- continuous glucose levels
Description
24h dynamics of glucose using continuous glucose monitor. substudy
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age >30 years with abdominal adiposity (waist circumference: men > 102 cm, women > 88 cm) or dyslipidemia (TG>150mg/dl and HDL-c <40mg/dL for men and <50mg/dL for women) Exclusion Criteria: Individuals who may not be able to partake in PA in the gym; TGs>400 mg/dL; serum creatinine>2 mg/dL; disturbed liver function; major illness that might require hospitalization; pregnant or lactating women; presence of active cancer, is receiving or received chemotherapy in the last three years; participation in another trial; participants who are treated with Coumadin (warfarin) - given its interaction with vitamin K and high level of this vitamin in "Mankai" green shake; pacemaker or platinum implant, because of the impossibility of MRI screening.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Iris Shai, PhD
Organizational Affiliation
Ben-Gurion University of the Negev
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nuclear research center Negev
City
Dimona
Country
Israel

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36175997
Citation
Zelicha H, Kloting N, Kaplan A, Yaskolka Meir A, Rinott E, Tsaban G, Chassidim Y, Bluher M, Ceglarek U, Isermann B, Stumvoll M, Quayson RN, von Bergen M, Engelmann B, Rolle-Kampczyk UE, Haange SB, Tuohy KM, Diotallevi C, Shelef I, Hu FB, Stampfer MJ, Shai I. The effect of high-polyphenol Mediterranean diet on visceral adiposity: the DIRECT PLUS randomized controlled trial. BMC Med. 2022 Sep 30;20(1):327. doi: 10.1186/s12916-022-02525-8.
Results Reference
derived
PubMed Identifier
35264213
Citation
Rinott E, Meir AY, Tsaban G, Zelicha H, Kaplan A, Knights D, Tuohy K, Scholz MU, Koren O, Stampfer MJ, Wang DD, Shai I, Youngster I. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial. Genome Med. 2022 Mar 10;14(1):29. doi: 10.1186/s13073-022-01015-z.
Results Reference
derived
PubMed Identifier
35021194
Citation
Kaplan A, Zelicha H, Yaskolka Meir A, Rinott E, Tsaban G, Levakov G, Prager O, Salti M, Yovell Y, Ofer J, Huhn S, Beyer F, Witte V, Villringer A, Meiran N, B Emesh T, Kovacs P, von Bergen M, Ceglarek U, Bluher M, Stumvoll M, Hu FB, Stampfer MJ, Friedman A, Shelef I, Avidan G, Shai I. The effect of a high-polyphenol Mediterranean diet (Green-MED) combined with physical activity on age-related brain atrophy: the Dietary Intervention Randomized Controlled Trial Polyphenols Unprocessed Study (DIRECT PLUS). Am J Clin Nutr. 2022 May 1;115(5):1270-1281. doi: 10.1093/ajcn/nqac001.
Results Reference
derived
PubMed Identifier
34643713
Citation
Tsaban G, Yaskolka Meir A, Zelicha H, Rinott E, Kaplan A, Shalev A, Katz A, Brikner D, Bluher M, Ceglarek U, Stumvoll M, Stampfer MJ, Shai I. Diet-induced Fasting Ghrelin Elevation Reflects the Recovery of Insulin Sensitivity and Visceral Adiposity Regression. J Clin Endocrinol Metab. 2022 Jan 18;107(2):336-345. doi: 10.1210/clinem/dgab681.
Results Reference
derived
PubMed Identifier
33461965
Citation
Yaskolka Meir A, Rinott E, Tsaban G, Zelicha H, Kaplan A, Rosen P, Shelef I, Youngster I, Shalev A, Bluher M, Ceglarek U, Stumvoll M, Tuohy K, Diotallevi C, Vrhovsek U, Hu F, Stampfer M, Shai I. Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial. Gut. 2021 Nov;70(11):2085-2095. doi: 10.1136/gutjnl-2020-323106. Epub 2021 Jan 18.
Results Reference
derived
PubMed Identifier
33234670
Citation
Tsaban G, Yaskolka Meir A, Rinott E, Zelicha H, Kaplan A, Shalev A, Katz A, Rudich A, Tirosh A, Shelef I, Youngster I, Lebovitz S, Israeli N, Shabat M, Brikner D, Pupkin E, Stumvoll M, Thiery J, Ceglarek U, Heiker JT, Korner A, Landgraf K, von Bergen M, Bluher M, Stampfer MJ, Shai I. The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial. Heart. 2020 Nov 23:heartjnl-2020-317802. doi: 10.1136/heartjnl-2020-317802. Online ahead of print.
Results Reference
derived
PubMed Identifier
32860791
Citation
Rinott E, Youngster I, Yaskolka Meir A, Tsaban G, Zelicha H, Kaplan A, Knights D, Tuohy K, Fava F, Scholz MU, Ziv O, Rubin E, Tirosh A, Rudich A, Bluher M, Stumvoll M, Ceglarek U, Clement K, Koren O, Wang DD, Hu FB, Stampfer MJ, Shai I. Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain. Gastroenterology. 2021 Jan;160(1):158-173.e10. doi: 10.1053/j.gastro.2020.08.041. Epub 2020 Aug 26.
Results Reference
derived
PubMed Identifier
30915471
Citation
Yaskolka Meir A, Tsaban G, Zelicha H, Rinott E, Kaplan A, Youngster I, Rudich A, Shelef I, Tirosh A, Brikner D, Pupkin E, Sarusi B, Bluher M, Stumvoll M, Thiery J, Ceglarek U, Stampfer MJ, Shai I. A Green-Mediterranean Diet, Supplemented with Mankai Duckweed, Preserves Iron-Homeostasis in Humans and Is Efficient in Reversal of Anemia in Rats. J Nutr. 2019 Jun 1;149(6):1004-1011. doi: 10.1093/jn/nxy321.
Results Reference
derived

Learn more about this trial

Effects of Green-MED Diet Via the Gut-fat-brain Axis

We'll reach out to this number within 24 hrs